Background: Leprosy is manifested in varied forms based on the immune status of the patient giving rise to the polar and borderline spectrum of tuberculoid (TT) and lepromatous leprosy (LL). The present study was conducted to assess the macrophage activation in the spectrum of leprosy using CD1a and Factor XIIIa immunohistochemical markers and to correlate the macrophage expression with the morphological spectrum and bacillary index.
Methodology: The present study was an observational study.
Results: The present study consisted of 40 biopsy-proven leprosy cases, in which a majority were males, and the most common age group was 20-40 years. The most common type encountered was borderline tuberculoid (BT) leprosy. Expression of epidermal dendritic cells and intensity of staining by CD1a was higher in TT (seven of 10 cases (70%)) when compared to LL (one of three cases (33%)). Similarly, Factor XIIIa showed higher expression of dermal dendritic cells in 90% of TT when compared to LL which was seen in 66%.
Conclusion: The increased number and strong intensity of dendritic cells in the tuberculoid spectrum may indirectly indicate macrophage activation and possibly account for the low bacillary index.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201461 | PMC |
| http://dx.doi.org/10.7759/cureus.37968 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Background: Germline haplodeficiency (RHD) is associated with thrombocytopenia, platelet dysfunction and predisposition to myeloid malignancies. Platelet expression profiling of a RHD patient showed decreased encoding for the A subunit of factor XIII, a transglutaminase that cross-links fibrin and induces clot stabilization. FXIII-A is synthesized by hematopoietic cells, megakaryocytes and monocytes.
View Article and Find Full Text PDFFactor XIII-A Transglutaminase Contributes to Neutrophil Extracellular Trap (NET)-mediated Fibrin(ogen) Network Formation and Crosslinking.
Thromb Haemost
January 2025
Division of Experimental Medicine, Department of Medicine, Faculty of Medicine and Health Sciences, McGill University, Montreal, Canada.
Background: Neutrophil extracellular traps can contribute to thrombosis via stabilization of fibrin network, which is normally conducted by plasma transglutaminase, Factor XIII-A as part of coagulation cascade. The possible presence and activity of FXIII-A in neutrophils or during NETosis are unknown. Here, we investigated potential presence of FXIII-A in neutrophils and participation in NET-fibrin(ogen) interaction in vitro METHODS: Data mining of human and mouse mRNA expression in whole-body scRNA sequence atlases was conducted.
View Article and Find Full Text PDFMast cells and factor XIIIa+ dendrocytes in actinic cheilitis and lip squamous cell carcinoma.
Braz Oral Res
December 2024
Universidade Federal de Minas Gerais - UFMG, School of Dentistry, Department of Oral Surgery, Pathology and Clinical Dentistry, Belo Horizonte, MG, Brazil.
There is an interaction between dendrocytes and mast cells in the skin. However, in elastosis-related diseases such as actinic cheilitis (AC) and lower lip squamous cell carcinoma (LLSCC), this interaction remains unknown. We investigated the presence of intact and degranulated mast cells in AC and LLSCC.
View Article and Find Full Text PDFFactor XIII Deficiency: Laboratory, Molecular, and Clinical Aspects.
Semin Thromb Hemost
November 2024
Department of Hematology, High Institute for Education and Research in Transfusion Medicine, Tehran, Iran.
Article Synopsis
- - FXIII-A deficiency is a rare bleeding disorder linked to serious complications like brain hemorrhages and miscarriages, with a higher prevalence of a milder form (heterozygous deficiency) found in up to 3.5% of the population.
- - Individuals with severe FXIII-A deficiency require consistent preventative treatment, while heterozygous individuals, especially women, may only need treatment during specific bleeding events.
- - Personalized treatment strategies based on individual patient factors (e.g., age, weight, and clinical situation) are essential for optimizing the effectiveness of therapy for FXIII deficiencies.
Ossifying Panniculitis Presenting as a Painful Nodule on the Abdomen.
Am J Dermatopathol
February 2025
Dermpath Diagnostics, Tampa, FL.
Myositis ossificans is a benign ossifying nodule that can affect any type of tissue but is most commonly found in muscle. Occurrence in the soft tissue of the subcutis is less common and has been referred to as panniculitis ossificans. In this case report, we describe a 46-year-old woman who presented with a 1.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!